1.
Zhi-Heng Chen, Xia Cao, Shou-Qing Huang, Guo-zhan Zhao, Ai Zeng Yang, Jian Wen, et al. Serological Thymidine Kinase1 is a Biomarker for Early Risk of Tumours Progression —Real World Data from a Health Screening Study on a Cohort of 35,365 People. NUPSR-V5 [Internet]. 2021 May 26 [cited 2026 Jun. 3];:36-65. Available from: https://stm.bookpi.org/NUPSR-V5/article/view/1398